On October 5th 2016, CM-Path invited industry representatives from pharmaceutical, molecular diagnostic and digital pathology companies to attend a workshop aimed at identifying solutions and barriers to the uptake of technologies in pathology. The agenda included presentations including:
- Molecular Diagnostics & the Pharmaceutical Industry – Stephen Hall, Novartis
- Successful Industry/NHS Collaborations – Dr Angela Silmon, NewGene
Adoption of New Technologies – Who Needs to be Involved – Dr Eddie Blair, BMS
- Digital Pathology Overview – Professor Peter Hall, Philips
- Overview of the BIVDA Digital Pathology Working Group – Barbara Fallowfield, BIVDA
The day also included break out discussions focussed on identifying solutions and barriers to technology uptake.